Copy
View this email in your browser
Dear Members –

The College has concerns about certain direct-to-consumer food allergy tests that are being performed and that do not take the patient’s medical history into account. Recently, it has come to our attention that Quest Direct is now offering various food allergy panel tests, including a “Food Allergy Test Panel,” “Nut Allergy Test Panel,” “Seafood Allergy Test Panel,” and “Shellfish Allergy Test Panel.”

Earlier today, we sent a letter to Quest stating that this type of serum IgE testing should only be used in conjunction with the patient’s full medical history, and in fact, the medical history is the most important part of any patient’s food allergy evaluation. This recommendation is a part of all food allergy diagnostic guidelines.

The College is very concerned that this form of direct-to-consumer testing provides more harm than benefit to individuals concerned about food allergy.

We have urged Quest to reconsider its direct-to-consumer food allergy serum IgE testing and to join ACAAI along with other national medical associations in following best practices for food allergy evaluation.

Sincerely,

Mark Corbett, MD
ACAAI President
 
 
 
Facebook Twitter LinkedIn YouTube Pinterest
 
 
Copyright © 2022 American College of Allergy, Asthma and Immunology, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list